Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Investors poured into a room at #JPM26 to see how Revolution Medicines' CEO would dance around questions they knew he ...
Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...
Ai Technology Group Inc. (OTCID:AIPG) (the “Company”) and AVM Biotechnology Inc. (“AVM”, the Washington State company that is the subject of the proposed merger) provide this joint press release. The ...
J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...
Using a technique called ancestral sequence reconstruction (ASR), researchers at Wageningen University & Research in the ...
Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area ...
A team of researchers led by bioengineer Shaochen Chen will use 3D printing techniques to shape stem cells produced by local firm Allele Biotechnology ...
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...
Eli Lilly’s presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical ...
He found that Brassicaceae vegetables are linked to lower cancer risk due to powerful phytochemicals like sulforaphane.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback